Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
about
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone.The Wilms' tumor gene-1 is a prognostic factor in myelodysplastic syndrome: a meta analysis.Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial
P2860
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@en
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@nl
type
label
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@en
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@nl
prefLabel
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@en
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@nl
P2093
P2860
P1433
P1476
Clinical evaluation of WT1 mRN ...... ith myelodysplastic syndromes.
@en
P2093
Akihisa Kanamaru
Akira Matsuda
Chisato Mizutani
Daisuke Koga
Fumimaro Takaku
Haruo Sugiyama
Hideto Tamura
Hirohiko Shibayama
Hiroya Tamaki
Hiroyasu Ogawa
P2860
P304
P356
10.3109/10428194.2012.745074
P577
2012-11-26T00:00:00Z